Your browser doesn't support javascript.
loading
Mfsd2a-mediated lysolipid transport is important for renal recovery after acute kidney injury.
Loke, Randy Y J; Chin, Cheen Fei; Liang, Gao; Wong, Bernice H; Galam, Dwight L A; Tan, Bryan C; Chua, Geok-Lin; Minegishi, Shintaro; Morisawa, Norihiko; Sidorov, Iulia; Heijs, Bram; Titze, Jens; Wenk, Markus R; Torta, Federico; Silver, David L.
Afiliación
  • Loke RYJ; Signature Research Program in Cardiovascular and Metabolic Disorders, Duke-National University of Singapore (NUS) Medical School, Singapore.
  • Chin CF; Signature Research Program in Cardiovascular and Metabolic Disorders, Duke-National University of Singapore (NUS) Medical School, Singapore.
  • Liang G; Singapore Lipidomics Incubator, Life Sciences Institute, NUS, Singapore; Department of Biochemistry, Yong Loo Lin School of Medicine, NUS, Singapore.
  • Wong BH; Signature Research Program in Cardiovascular and Metabolic Disorders, Duke-National University of Singapore (NUS) Medical School, Singapore.
  • Galam DLA; Signature Research Program in Cardiovascular and Metabolic Disorders, Duke-National University of Singapore (NUS) Medical School, Singapore.
  • Tan BC; Signature Research Program in Cardiovascular and Metabolic Disorders, Duke-National University of Singapore (NUS) Medical School, Singapore.
  • Chua GL; Signature Research Program in Cardiovascular and Metabolic Disorders, Duke-National University of Singapore (NUS) Medical School, Singapore.
  • Minegishi S; Signature Research Program in Cardiovascular and Metabolic Disorders, Duke-National University of Singapore (NUS) Medical School, Singapore.
  • Morisawa N; Signature Research Program in Cardiovascular and Metabolic Disorders, Duke-National University of Singapore (NUS) Medical School, Singapore.
  • Sidorov I; Center of Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands; The Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW), Leiden University Medical Center, Leiden, the Netherlands.
  • Heijs B; Center of Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands; The Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW), Leiden University Medical Center, Leiden, the Netherlands.
  • Titze J; Signature Research Program in Cardiovascular and Metabolic Disorders, Duke-National University of Singapore (NUS) Medical School, Singapore.
  • Wenk MR; Singapore Lipidomics Incubator, Life Sciences Institute, NUS, Singapore; Department of Biochemistry, Yong Loo Lin School of Medicine, NUS, Singapore.
  • Torta F; Singapore Lipidomics Incubator, Life Sciences Institute, NUS, Singapore; Department of Biochemistry, Yong Loo Lin School of Medicine, NUS, Singapore.
  • Silver DL; Signature Research Program in Cardiovascular and Metabolic Disorders, Duke-National University of Singapore (NUS) Medical School, Singapore. Electronic address: david.silver@duke-nus.edu.sg.
J Lipid Res ; 64(8): 100416, 2023 08.
Article en En | MEDLINE | ID: mdl-37467896
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Simportadores / Lesión Renal Aguda Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: J Lipid Res Año: 2023 Tipo del documento: Article País de afiliación: Singapur Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Simportadores / Lesión Renal Aguda Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: J Lipid Res Año: 2023 Tipo del documento: Article País de afiliación: Singapur Pais de publicación: Estados Unidos